59 results
Page 2 of 3
424B7
e2o7y
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
pf0t6c48qz nv
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
EX-99.1
64oqdvtdv
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.2
3b4bvyl8mkzy3he
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.2
9w4auoxbtcs4l
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
aaiz1rbqe0p
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.2
78h0to3jftx
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.3
n24a6
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
xue6wtyj14b
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
0l45kath
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
424B5
dnes2liudve6ez
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
qcivlefztw hq676ek
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.1
psf4pt5fxjtrhkrijmko
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
424B5
gdoxy6
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
eme p0kso
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
zpc7l7
1 Jul 20
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
6:15am
6-K
EX-99.1
tkopaol msjclurrpy
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am